349 related articles for article (PubMed ID: 31178377)
1. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
[TBL] [Abstract][Full Text] [Related]
2. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.
Ella R; Bobba R; Muralidhar S; Babji S; Vadrevu KM; Bhan MK
Hum Vaccin Immunother; 2018 Jul; 14(7):1791-1799. PubMed ID: 29543547
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of two monovalent rotavirus vaccines, ROTAVAC® and ROTAVAC 5D® in Zambian infants.
Chilengi R; Mwila-Kazimbaya K; Chirwa M; Sukwa N; Chipeta C; Velu RM; Katanekwa N; Babji S; Kang G; McNeal MM; Meyer N; Gompana G; Hazra S; Tang Y; Flores J; Bhat N; Rathi N
Vaccine; 2021 Jun; 39(27):3633-3640. PubMed ID: 33992437
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684685
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial.
Kanungo S; Chatterjee P; Bavdekar A; Murhekar M; Babji S; Garg R; Samanta S; Nandy RK; Kawade A; Boopathi K; Kanagasabai K; Kamal VK; Kumar VS; Gupta N; Dutta S
Lancet Infect Dis; 2022 Aug; 22(8):1191-1199. PubMed ID: 35588754
[TBL] [Abstract][Full Text] [Related]
6. A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Rathi N; Desai S; Kawade A; Venkatramanan P; Kundu R; Lalwani SK; Dubey AP; Venkateswara Rao J; Narayanappa D; Ghildiyal R; Gogtay N; Venugopal P; Palkar S; Munshi R; Kang G; Babji S; Bavdekar A; Juvekar S; Ganguly N; Niyogi P; Ghosh Uttam K; Rajani HS; Kondekar A; Kumbhar D; Mohanlal S; Agarwal MC; Shetty P; Antony K; Gunale B; Dharmadhikari A; Tang Y; Kulkarni PS; Flores J
Vaccine; 2018 Dec; 36(52):7943-7949. PubMed ID: 30420116
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.
Kawade A; Babji S; Kamath V; Raut A; Kumar CM; Kundu R; Venkatramanan P; Lalwani SK; Bavdekar A; Juvekar S; Dayma G; Patil R; Kulkarni M; Hegde A; Nayak D; Garg BS; Gupta S; Jategaonkar S; Bedi N; Maliye C; Ganguly N; Uttam KG; Niyogi P; Palkar S; Hanumante N; Goyal N; Arya A; Aslam M; Parulekar V; Dharmadhikari A; Gaikwad D; Zade J; Desai S; Kang G; Kulkarni PS
Vaccine; 2019 May; 37(19):2554-2560. PubMed ID: 30955982
[TBL] [Abstract][Full Text] [Related]
8. Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
Desai S; Rathi N; Kawade A; Venkatramanan P; Kundu R; Lalwani SK; Dubey AP; Venkateswara Rao J; Narayanappa D; Ghildiyal R; Gogtay NJ; Venugopal P; Palkar S; Munshi R; Bavdekar A; Juvekar S; Ganguly N; Niyogi P; Uttam KG; Kondekar A; Kumbhar D; Mohanlal S; Agarwal MC; Shetty P; Antony K; Gunale B; Dharmadhikari A; Deshpande J; Nalavade U; Sharma D; Bansal A; Tang Y; Flores J; Kulkarni PS
Vaccine; 2018 Sep; 36(37):5519-5523. PubMed ID: 30104114
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity, safety and reactogenicity of ROTAVAC® in healthy infants aged 6-8 weeks in Vietnam.
Hai NM; Dung ND; Pho DC; Son VT; Hoan VN; Dan PT; The Anh BD; Giang H; Hung PN
Vaccine; 2021 Feb; 39(7):1140-1147. PubMed ID: 33461837
[TBL] [Abstract][Full Text] [Related]
10. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008521. PubMed ID: 30912133
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
[TBL] [Abstract][Full Text] [Related]
12. A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants.
Cohet C; Cheuvart B; Moerman L; Bi D; Caplanusi A; Kariyappa M; Lalwani S; Mitra M; Sapru A; Saha S; Varughese PV; Kompithra RZ; Gandhi S
Hum Vaccin Immunother; 2021 Nov; 17(11):4646-4653. PubMed ID: 34428112
[TBL] [Abstract][Full Text] [Related]
13. Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants.
P KK; Chiteti SR; Aileni VK; Babji S; Blackwelder WC; Kumar A; Vagha J; Nayak U; Mitra M; D N; Kar S; Yadav S; Naidu S; Mahantshetti N; Khalatkar V; Mohapatra S; Purthi PK; Sharma P; Kannan A; Dhongade RK; Prasad SD; Ella R; Vadrevu KM
Hum Vaccin Immunother; 2023 Dec; 19(3):2278346. PubMed ID: 37968237
[TBL] [Abstract][Full Text] [Related]
14. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial.
Ali SA; Kazi AM; Cortese MM; Fleming JA; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi A
J Infect Dis; 2014 Dec; 210(11):1772-9. PubMed ID: 24939906
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Bergman H; Henschke N; Hungerford D; Pitan F; Ndwandwe D; Cunliffe N; Soares-Weiser K
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD008521. PubMed ID: 34788488
[TBL] [Abstract][Full Text] [Related]
16. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial.
Ali A; Kazi AM; Cortese MM; Fleming JA; Moon S; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi AK
PLoS One; 2015; 10(6):e0127622. PubMed ID: 26035743
[TBL] [Abstract][Full Text] [Related]
17. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of different dosing schedules of the human live attenuate rotavirus vaccine (RV1) in infants and children: a meta-analysis.
Dai X; Bai R; Jian M; Ji Z; Ding Z; Wang F; Bi Y; Manzamaesso A; Chen T; Luo L; Liu A; Bao F
Hum Vaccin Immunother; 2019; 15(6):1228-1236. PubMed ID: 30346870
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.
Salinas B; Pérez Schael I; Linhares AC; Ruiz Palacios GM; Guerrero ML; Yarzábal JP; Cervantes Y; Costa Clemens S; Damaso S; Hardt K; De Vos B
Pediatr Infect Dis J; 2005 Sep; 24(9):807-16. PubMed ID: 16148848
[TBL] [Abstract][Full Text] [Related]
20. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
